Avoro Capital Advisors LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$569.9B
Holdings
44
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SRPTSAREPTA THERAPUTICS INC | 1,635,509 | $90.2B | 15.82% | Put |
| 2 | BMRNBIOMARIN PHARMACEUTICAL INC | 419,712 | $38.8B | 6.81% | |
| 3 | —LION BIOTECHNOLOGIES INC | 4,257,347 | $35.0B | 6.15% | |
| 4 | —TESARO INC | 277,703 | $27.8B | 4.88% | |
| 5 | AGENEURAGENUS INC | 4,715,938 | $27.5B | 4.82% | Call |
| 6 | AM6AMICUS THERAPEUTICS INC | 3,689,857 | $27.3B | 4.79% | |
| 7 | —DERMIRA INC | 805,926 | $27.3B | 4.78% | |
| 8 | ACADACADIA PHARMACEUTICALS INC | 792,499 | $25.2B | 4.42% | |
| 9 | NBIXNEUROCRINE BIOSCIENCES INC | 490,582 | $24.8B | 4.36% | |
| 10 | —IMMUNOMEDICS INC | 7,644,977 | $23.9B | 4.20% | Call |
| 11 | BMYBRISTOL MYERS SQUIBB CO. | 399,875 | $21.6B | 3.78% | |
| 12 | GBTUSDGLOBAL BLOOD THERAPEUTICS | 869,263 | $20.0B | 3.52% | |
| 13 | AERIEURAERIE PHARMACEUTICALS INC | 500,000 | $18.9B | 3.31% | |
| 14 | —GW PHARMACEUTICALS PLC | 133,600 | $17.7B | 3.11% | |
| 15 | VNDAVANDA PHARMACEUTICALS INC | 827,693 | $13.8B | 2.42% | |
| 16 | —NEURODERM LTD | 686,303 | $12.7B | 2.23% | |
| 17 | —TELIGENT INC | 1,637,819 | $12.4B | 2.18% | |
| 18 | SRNESORRENTO THERAPEUTICS INC | 1,531,273 | $11.9B | 2.08% | |
| 19 | MRTXEURMIRATI THERAPEUTICS INC | 1,488,487 | $9.8B | 1.73% | |
| 20 | —CASCADIAN THERAPEUTICS INC | 5,611,323 | $9.2B | 1.61% | |
| 21 | AKBAAKEBIA THERAPEUTICS INC | 944,579 | $8.5B | 1.50% | |
| 22 | AGIOAGIOS PHARMACEUTICALS INC | 150,000 | $7.9B | 1.39% | |
| 23 | SGENEURSEATTLE GENETICS INC | 141,500 | $7.6B | 1.34% | |
| 24 | VCYTVERACYTE INC | 918,556 | $7.0B | 1.23% | |
| 25 | BCRXBIOCRYST PHARMACEUTICALS INC | 1,379,402 | $6.1B | 1.07% | |
| 26 | —ALIMERA SCIENCES INC | 3,575,000 | $5.3B | 0.93% | |
| 27 | TREURTRILLIUM THERAPEUTICS INC | 316,020 | $4.7B | 0.82% | |
| 28 | CRVSCORVUS PHARMACEUTICALS INC | 268,369 | $4.4B | 0.77% | |
| 29 | —FORTRESS BIOTECH INC | 1,356,636 | $4.0B | 0.71% | |
| 30 | —PROTEOSTASIS THERAPEUTICS INC | 179,565 | $2.8B | 0.49% | |
| 31 | —INNOCOLL HOLDINGS PLC | 468,148 | $2.7B | 0.48% | |
| 32 | —PERNIX THERAPEUTICS HOLDINGS INC | 7,000,000 | $2.0B | 0.36% | |
| 33 | ASMBASSEMBLY BIOSCIENCES INC | 268,119 | $1.9B | 0.34% | |
| 34 | —ONCOBIOLOGICS INC | 450,872 | $1.9B | 0.34% | |
| 35 | CLLSCELLECTIS - ADR | 58,671 | $1.4B | 0.25% | |
| 36 | —VERSARTIS INC | 95,742 | $1.2B | 0.21% | |
| 37 | —ONCOMED PHARMACEUTICALS INC | 85,000 | $972.0M | 0.17% | |
| 38 | ASNDASCENDIS PHARMA | 45,203 | $909.0M | 0.16% | |
| 39 | —CEMPRA INC | 30,000 | $726.0M | 0.13% | |
| 40 | VCELVERICEL CORP | 215,744 | $604.0M | 0.11% | |
| 41 | —NANTKWEST INC | 72,412 | $563.0M | 0.10% | |
| 42 | —DICERNA PHARMACEUTICALS INC | 46,082 | $271.0M | 0.05% | |
| 43 | —ONCOBIOLOGICS INC - WARRANT B | 233,333 | $233.0M | 0.04% | |
| 44 | —ONCOBIOLOGICS INC - WARRANT A | 233,333 | $112.0M | 0.02% |